Bipolar Disorder Trial, Recruiting (NCT06743711)

Bipolar Disorder Trial, Recruiting NCT06743711 Sponsor: Bjorn H. Ebdrup Condition: Bipolar Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06743711 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bipolar Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 45 years old
You have been diagnosed with a schizophrenia-related condition or a mood/affective disorder (such as bipolar disorder or major depression) (confirm with trial site for your specific diagnosis)
You have been taking antipsychotic medication every day for more than one month
You are able to understand and agree to participate in the study on your own

Who may not be able to join:

You have a serious physical health condition or abnormal lab results that are not well managed or controlled
Your psychiatric (mental health) condition is currently unstable
You are currently considered to be at immediate risk of suicide
You are expected to be admitted to a hospital at any point during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bjørn H Ebdrup, Professor and psychiatrist, Mental Health Center Glostrup, Center for Neuropsychiatric Schizophrenia Research

Phone: +4538640840

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06743711

Sponsor: Bjorn H. Ebdrup

Phase: Not Applicable

Status: Recruiting

Condition: Bipolar Disorder

Trial contact: +4538640840

More information: https://clinicaltrials.gov/study/NCT06743711

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 45 years old
You have been diagnosed with a schizophrenia-related condition or a mood/affective disorder (such as bipolar disorder or major depression) (confirm with trial site for your specific diagnosis)
You have been taking antipsychotic medication every day for more than one month
You are able to understand and agree to participate in the study on your own

Who may not be able to join:

You have a serious physical health condition or abnormal lab results that are not well managed or controlled
Your psychiatric (mental health) condition is currently unstable
You are currently considered to be at immediate risk of suicide
You are expected to be admitted to a hospital at any point during the study period

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bjorn H. Ebdrup

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

30 June 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Estimated VO2max

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov